Recent Advances in Clinical Trials

Recent Advances in Clinical Trials

Open Access
ISSN: 2771-9057
Case Report

Mesenchymal Hamartoma of the Liver Associated with Discontinuity of the Vena Cava

Authors: LAMARA Abdelhak, BOUKHANE Mohamed, GADDA Mounir, BELKADI Rayad, MEDJAHDI Sid Ahmed, HAMHOUM Nessrine, BLEL Samira, MADOUI Dahmane, SELMANI Khaled.

DOI: 10.33425/2771-9057.1026


Abstract

Primary liver tumors in children are infrequent, accounting for 0.5-2 % of all pediatric neoplasms. About two-thirds are malignant. The most common pediatric malignant liver tumours are, in order of frequency, hepatoblastoma, hepatocellular carcinoma, and embryonic sarcoma of the liver. Among benign tumors, the most frequent are hemangioendothelioma and mesenchymal hamartoma of the liver, and more rarely focal nodular hyperplasia and hepatocellular adenoma [1,2].

We report the case of an infant who was entrusted to us for the management of a large liver tumor. Radiology (CT scan and MRI), in addition to the elements in favor of a mesenchymal hamartoma of the right liver revealed a congenital anomaly associated, in this case, with the absence of the inferior vena cava in its intraabdominal portion. A right hepatectomy enlarged to segment IV was performed.

The right renal vein drained into the right suprahepatic vein was preserved. Note that this tumor represents 50% of the total weight of the patient, which explains the difficulties and constraints that hindered the development and quality of life of the young patient.

View / Download PDF
Citation: LAMARA Abdelhak, BOUKHANE Mohamed, GADDA Mounir, et al. Mesenchymal Hamartoma of the Liver Associated with Discontinuity of the Vena Cava. 2023; 3(2). DOI: 10.33425/2771-9057.1026
Editor-in-Chief
Mike Robinson
Mike Robinson
Medical Department | Global Cannabinoid Research Center

View full editorial board →
Journal Metrics
Impact Factor 2.9*
Acceptance Rate 80%
Time to first decision 5-8 Days
Submission to acceptance 12-15 Days